Commitments and Contingencies (Details Textual) (USD $)	3 Months Ended		9 Months Ended			1 Months Ended		7 Months Ended	12 Months Ended	3 Months Ended	12 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011	Dec. 31, 2011	Feb. 29, 2012 Albo Graft Vascular Graft [Member]	Oct. 31, 2011 Albo Graft Vascular Graft [Member]	Sep. 30, 2012 Albo Graft Vascular Graft [Member]	Dec. 31, 2011 France and United Kingdom [Member]	Mar. 31, 2012 Cost of Sales [Member]	Dec. 31, 2011 Cost of Sales [Member]
Loss Contingencies [Line Items]
AlboGraft device failures, Complaint received							2
AlboGraft device failures, Additional Complaint received						2		4
Inventory write-offs			$ 947,000	$ 772,000						$ 100,000	$ 200,000
Net sales	13,645,000	14,564,000	41,934,000	44,274,000					1,000,000
Inventories	10,130,000		10,130,000		8,003,000			2,300,000
Other intangibles, net	2,415,000		2,415,000		2,985,000			500,000
Commitments and Contingencies (Textual) [Abstract]
Commitments to purchase inventory	2,000,000		2,000,000
Intangible asset acquired	27,000		27,000
Purchase Commitments Inventory Expire Year	2017		2017
Intangible assets related to earn-out Payments on domestic sales			100,000
Contingent payment	$ 100,000		$ 100,000
Major Customer Volume			0.40
Earn-out payments ratio sale	200.00%		200.00%